Possible side effects include:
Selective serotonin reuptake inhibitors (SSRIs) are used to treat the depression that may accompany chronic fatigue syndrome. Some believe they may also be beneficial for CFS even if you are not depressed. Improvement may be seen in four to six weeks after beginning treatment.
Common names include:
Selective serotonin reuptake inhibitors (SSRIs) affect the concentration of the neurotransmitter serotonin, which plays a role in anxiety and may therefore help to treat panic disorders.
Common names include:
Selective serotonin reuptake inhibitors (SSRIs) affect the concentration of the neurotransmitter serotonin, which plays a role in anxiety and may therefore help to treat panic disorders.
Common names include:
Selective serotonin reuptake inhibitors (SSRIs) affect the concentration of the neurotransmitter serotonin, which plays a role in anxiety. Although they are considered Although these drugs are considered to be antidepressants, SSRIs have been used effectively for the treatment of panic and other anxiety disorders. Improvement is usually seen in 4-6 weeks after beginning treatment. SSRIs are not addictive. Do not take an SSRI if you have taken an MAOI in the last 2-5 weeks.
Selective serotonin reuptake inhibitors (SSRIs) affect the concentration of the neurotransmitter serotonin, which plays a role in anxiety and may therefore help to treat panic disorders.
Common names include:
Although these drugs are considered to be antidepressants, SSRIs have been used effectively for the treatment of panic and other anxiety disorders. Improvement is usually seen in 4-6 weeks after beginning treatment. SSRIs are not addictive. Do not take an SSRI if you have taken an MAOI in the last 2-5 weeks.
Selective serotonin reuptake inhibitors (SSRIs) are a class of pharmacological antidepressants. They are currently the most popular class of antidepressant medications because of their relative safety in comparison to monoamine oxidase inhibitors (MAOIs) and tricyclics (TCAs). In addition to being prescribed for depression, SSRIs are sometimes prescribed for General Anxiety Disorder as well.
]4]). Selective serotonin reuptake inhibitors (SSRIs) are a class of pharmacological antidepressants. They are currently the most popular class of antidepressant medications because of their relative safety in comparison to monoamine oxidase inhibitors (MAOIs) and tricyclics (TCAs). In addition to being prescribed for [depression, SSRIs are sometimes prescribed for General Anxiety Disorder as well.
Common names include:
Selective serotonin reuptake inhibitors (SSRIs) affect the concentration of the neurotransmitter serotonin, which plays a role in anxiety. Although Serotonin is a neurotransmitter with calming effects, and oftentimes people with anxiety do not have adequate amounts of serotonin. Thus, although they are considered antidepressants, SSRIs have been used effectively for the treatment of anxiety disorders.
Improvement is usually seen in four to six weeks after beginning treatment.
Common names include:
Possible side effects of SSRIs include:
Gastrointestinal upset is the most common side effect that users experience. These include nausea, diarrhea, and cramping. It is commonly recommended that users take SSRIs with food and an antacid or antiemetic for the first 2-3 weeks of treatment.
SSRIs also activate the central nervous system, which can result in agitation, anxiety, restlessness, and insomnia.
FDA issued a warning that combining an SSRI with one of the commonly-used "triptan" medications for migraine headaches can cause serious side effects such as agitation, hallucinations, elevated body temperature, and rapid changes in blood pressure. (6)
Other side effects can include headache, dry mouth, excessive sweating, tremor, and sexual dysfunction.
Do not take selective serotonin inhibitors (SSRIs) with monoamine inhibitors (MAOIs).
The first SSRI on the market was fluoxetine (Prozac). The newer agents are: citalopram (Celexa), escitalopram (Lexapro), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft).8 They all share the same side effects but in varying degrees. Unlike TCAs, they interact very little with other receptors besides the serotonin 5-HT reuptake receptor. Their side effects tend to be related to increased serotonin activity: nausea, gastrointestinal upset, sweating, anxiety, insomnia, headache, restlessness, and sexual dysfunction. This class of drugs is prescribed for mild to moderate depression.8
Selective serotonin reuptake inhibitors (SSRIs) affect the concentration of the neurotransmitter serotonin, which plays a role in anxiety. Serotonin is a neurotransmitter with calming effects, and oftentimes people with anxiety do not have adequate amounts of serotonin. Thus, although they are considered antidepressants, SSRIs have been used effectively for the treatment of anxiety disorders.
Improvement is usually seen in four to six weeks after beginning treatment.
Common names include:
Help improve this article. Become a contributercontributor!
Selective serotonin reuptake inhibitors (SSRIs) are the newest class of pharmacological antidepressants. They are currently the most popular class of antidepressant medications because of their relative safety in comparison to monoamine oxidase inhibitors (MAOIs) and tricyclics (TCAs).
Help improve this article. Become a contributor!
Selective serotonin reuptake inhibitors (SSRIs) are the newest class of pharmacological antidepressants. They are currently the most popular class of antidepressant medications because of their relative safety in comparison to monoamine oxidase inhibitors (MAOIs) and tricyclics (TCAs).
SSRIs work by selectively blocking serotonin reuptake receptors, increasing the levels of serotonin in the synaptic clefts (spaces between neurons) of the brain. SSRIs are safer in overdose and fewer side effects than other antidepressant medications.
Selective serotonin reuptake inhibitors (SSRIs) are a class of pharmacological antidepressants. They are currently the most popular class of antidepressant medications because of their relative safety in comparison to monoamine oxidase inhibitors (MAOIs) and tricyclics (TCAs).
Studies show that selective serotonin reuptake inhibitors (SSRIs) are as effective as tricyclics (TCAs), but with greater safety in use, greater ease in dosage, and less side effects. SSRIs have been shown to be effective for mild to moderate forms of depression. Other treatments should be considered for more severe types of depression.
Some studies have shown that it is more difficult for people with low folate levels to experiences the beneficial side effects of SSRIs and therefor supplementation may be warranted.7
Read more on Depression and Folate
1 Charney, D.S & Delgado, P.L. (1992). Current concepts of serotonin neuronal function and the pathophysiology of depression. Experimental Approaches to Anxiety and Depression. San Antonio: Wiley.
2 DeBaffista, C. (1997). Medical Management of Depression. Durant: EMIS, Inc.
3 Moncrieff, J., Wessely S., & Hardy R. (2008). Active placebos versus antidepressants for depression. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD003012. DOI: 10.1002/14651858.CD003012.pub2
4 Biggs, J.T., Spiker D.C., Petit J.M. et al. (1977). Tricyclic Antidepressant overdose: Incidence and Symptoms. Journal of the American Medical Association, 238.
5 Micó J., Ardid D., Berrocoso E., & Eschalier A. (2006). Antidepressants and pain. Trends in Pharmacological Sciences, 27(7).
6 Depression Handbook, National Institute of Mental Health, 2008
7 Alpert, M., Silvia, R.R. & Pouger, E.R. (2003). Prediction of Treatment REsponse in Geriatric Depression from Baseline Folate Level: Interaction with an SSRO or a Tricyclic Antidepressant. Journal of Clinical Psychopharmacol23, 309-313.
8 Preston, J. D., O'Neal, J. H., & Talaga, M. C. (2005). Handbook of clinical psychopharmacology for therapists. Oakland, CA: New Harbinger Publications, Inc.
Selective serotonin reuptake inhibitors (SSRIs) have also been shown to be effective in treating obsessive compulsive disorder (OCD), panic disorder, and eating disorders for some people.
